B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer

Clinical Immunology

Volumn 129, Issue 3, 2008, Pages 471-481

  Liu, Yu ^a   Zeng, Bin ^a   Zhang, Zhuohan ^a   Zhang, Yuan ^a   Yang, Rongcun ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

B7 H1; ; Immune suppression; Myeloid derived suppressor cells;

Indexed keywords

B7 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; MEMBRANE ANTIGEN; PD 1 ANTIGEN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; ASCITES; BONE MARROW CELL; CANCER MODEL; CD4+ CD25+ T LYMPHOCYTE; COCULTURE; CONTROLLED STUDY; IMMUNE RESPONSE; KNOCKOUT GENE; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN; SUPPRESSOR CELL; TUMOR GROWTH;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD11B; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOPHENOTYPING; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MYELOID CELLS; OVARIAN NEOPLASMS; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; TRANSFECTION;

EID: 55249113863     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.07.030     Document Type: Article

References (49)

1. Young MR., Wright M.A., Matthews J.P., Malik I., and Prechel M. Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide. J. Immunol. 156 (1996) 1916-1922
2. Otsuji M., Kimura Y., Aoe T., Okamoto Y., and Saito T. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 13119-13124
3. Kono K., Salazar-Onfray F., Petersson M., Hansson J., Masucci G., Wasserman K., Nakazawa T., Anderson P., and Kiessling R. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell- and natural killer cell-mediated cytotoxicity. Eur. J. Immunol. 26 (1996) 1308-1313
4. Fu Y.X., Watson G.A., asahara M.K., and Lopez D.M. The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF. J. Immunol. 146 (1991) 783-789
5. Serafini P., De Santo C., Marigo I., Cingarlini S., Dolcetti L., Gallina G., Zanovello P., and Bronte V. Derangement of immune responses by myeloid suppressor cells. Cancer Immunol. Immunother. 53 (2004) 64-72
6. Melani C., Chiodoni C., Forni G., and Colombo M.P. Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. Blood 102 (2003) 2138-2145
7. Bronte V., Serafini P., Apolloni E., and Zanovello P. Tumor-induced immune dysfunctions caused by myeloid suppressor cells. J. Immunother. 24 (2001) 431-446
8. Kusmartsev S., and Gabrilovich D.I. Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species. J. Leukoc. Biol. 74 (2003) 186-196
9. Goddard S., Youster J., Morgan E., and Adams D.H. Interleukin-10 secretion differentiates dendritic cells from human liver and skin. Am. J. Pathol. 164 (2004) 511-519
10. Halliday G.M., and Le S. Transforming growth factor-beta produced by progressor tumors inhibits, while IL-10 produced by regressor tumors enhances, Langerhans cell migration from skin. Int. Immunol. 13 (2001) 1147-1154
11. Chomarat P., Banchereau J., Davoust J., and Palucka A.K. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 1 (2000) 510-514
12. Sombroek C.C., Stam A.G., Masterson A.J., Lougheed S.M., Schakel M.J., Meijer C.J., Pinedo H.M., van den Eertwegh A.J., Scheper R.J., and de Gruijl T.D. Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation. J. Immunol. 168 (2002) 4333-4343
13. Mazzoni A., Bronte V., Visintin A., Spitzer J.H., Apolloni E., Serafini P., Zanovello P., and Segal D.M. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J. Immunol. 168 (2002) 689-695
14. Apolloni E., Bronte V., Mazzoni A., Serafini P., Cabrelle A., Segal D.M., Young H.A., and Zanovello P. Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes. J. Immunol. 165 (2000) 6723-6730
15. Bronte V., Wang M., Overwijk W.W., Surman D.R., Pericle F., Rosenberg S.A., and Restifo N.P. Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells. J. Immunol. 161 (1998) 5313-5320
16. Bronte V., Chappell D.B., Apolloni E., Cabrelle A., Wang M., Hwu P., and Restifo N.P. Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. J. Immunol. 162 (1999) 5728-5737
17. Almand B., Clark J.I., Nikitina E., van Beynen J., English N.R., Knight S.C., Carbone D.P., and Gabrilovich D.I. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol. 166 1 (2001) 678-689
18. Subudhi S.K., Alegre M.L., and Fu Y.X. The balance of immune responses: costimulation verse coinhibition. J. Mol. Med. 83 (2005) 193-202
19. Greenwald R.J., Freeman G.J., and Sharpe A.H. The B7 family revisited. Annu. Rev. Immunol. 23 (2005) 515-548
20. Yao S., and Chen L. Reviving exhausted T lymphocytes during chronic virus infection by B7-H1 blockade. Trends Mol. Med. 12 (2006) 244-246
21. Day C.L., Kaufmann D.E., Kiepiela P., Brown J.A., Moodley E.S., Reddy S., Mackey E.W., Miller J.D., Leslie A.J., DePierres C., Mncube Z., Duraiswamy J., Zhu B., Eichbaum Q., Altfeld M., Wherry E.J., Coovadia H.M., Goulder P.J., Klenerman P., Ahmed R., Freeman G.J., and Walker B.D. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443 (2006) 350-354
22. Chiou S.H., Sheu B.C., Chang W.C., Huang S.C., and Hong-Nerng H. Current concepts of tumor-infiltrating lymphocytes in human malignancies. J. Reprod. Immunol. 67 (2005) 35-50
23. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., Freeman G.J., and Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439 (2006) 682-687
24. Curiel T.J., Wei S., Dong H., Alvarez X., Cheng P., Mottram P., Krzysiek R., Knutson K.L., Daniel B., Zimmermann M.C., David O., Burow M., Gordon A., Dhurandhar N., Myers L., Berggren R., Hemminki A., Alvarez R.D., Emilie D., Curiel D.T., Chen L., and Zou W. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat. Med. 9 (2003) 562-567
25. Curiel T.J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., Evdemon-Hogan M., Conejo-Garcia J.R., Zhang L., Burow M., Zhu Y., Wei S., Kryczek I., Daniel B., Gordon A., Myers L., Lackner A., Disis M.L., Knutson K.L., Chen L., and Zou W. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10 (2004) 942-949
26. Kryczek I., Wei S., Zhu G., Myers L., Mottram P., Cheng P., Chen L., Coukos G., and Zou W. Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Res. 67 (2007) 8900-8905
27. Blank C., Kuball J., Voelkl S., Wiendl H., Becker B., Walter B., Majdic O., Gajewski T.F., Theobald M., Andreesen R., and Mackensen A. Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro. Int. J. Cancer 119 (2006) 317-327
28. Ohigashi Y., Sho M., Yamada Y., Tsurui Y., Hamada K., Ikeda N., Mizuno T., Yoriki R., Kashizuka H., Yane K., Tsushima F., Otsuki N., Yagita H., Azuma M., and Nakajima Y. Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer. Clin. Cancer Res. 11 (2005) 2947-2953
29. Roby K.F., Taylor C.C., Sweetwood J.P., Cheng Y., Pace J.L., Tawfik O., Persons D.L., Smith P.G., and Terranova P.F. Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis 21 (2000) 585-591
30. Yang R., Cai Z., Zhang Y., Ht Yutzy W., Roby K.F., and Roden R.B. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells. Cancer Res. 66 (2006) 6807-6815
31. Yang R., Murillo F.M., Cui H., Blosser R., Uematsu S., Takeda K., Akira S., Viscidi R.P., and Roden R.B. Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88. J. Virol. 78 (2004) 11152-11160
32. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21 (2003) 685-711
33. Probst H.C., Lagnel J., Kollias G., and van den Broek M. Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. Immunity 18 (2003) 713-720
34. Moser M. Dendritic cells in immunity and tolerance-do they display opposite functions?. Immunity 19 (2003) 5-8
35. Juedes A.E., and Von Herrath M.G. Using regulatory APCs to induce/maintain tolerance. Ann. N. Y. Acad. Sci. 1005 (2003) 128-137
36. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12 (2000) 431-440
37. Read S., Malmstrom V., and Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192 (2000) 295-302
38. + regulatory T cells. J. Immunol. 173 (2004) 4433-4442
39. Blazar B.R., Carreno B.M., Panoskaltsis-Mortari A., Carter L., Iwai Y., Yagita H., Nishimura H., and Taylor P.A. Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism. J. Immunol. 171 (2003) 1272-1277
40. Salama A.D., Chitnis T., Imitola J., Ansari M.J., Akiba H., Tushima F., Azuma M., Yagita H., Sayegh M.H., and Khoury S.J. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198 (2003) 71-78
41. Ansari M.J., Salama A.D., Chitnis T., Smith R.N., Yagita H., Akiba H., Yamazaki T., Azuma M., Iwai H., Khoury S.J., Auchincloss Jr. H., and Sayegh M.H. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198 (2003) 63-69
42. Kusmartsev S., Nefedova Y., Yoder D., and Gabrilovich D.I. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J. Immunol. 172 (2004) 989-999
43. Young M.R., Young M.E., and Wright M.A. Myelopoiesis-associated suppressor-cell activity in mice with Lewis lung carcinoma tumors: interferon-gamma plus tumor necrosis factor-alpha synergistically reduce suppressor cell activity. Int. J. Cancer 46 (1990) 245-250
44. Kucia M., Reca R., Miekus K., Wanzeck J., Wojakowski W., Janowska-Wieczorek A., Ratajczak J., and Ratajczak M.Z. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23 (2005) 879-894
45. Yamaguchi H., Wyckoff J., and Condeelis J. Cell migration in tumors. Curr. Opin. Cell Biol. 17 (2005) 559-564
46. Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat. Rev. Cancer 5 (2005) 263-274
47. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4 (2004) 71-78
48. Engleman E.G., Brody J., and Soares L. Using signaling pathways to overcome immune tolerance to tumors. Sci. STKE (2004) pe28
49. Habicht A., Dada S., Jurewicz M., Fife B.T., Yagita H., Azuma M., Sayegh M.H., and Guleria I. A link between PDL1 and T regulatory cells in fetomaternal tolerance. J. Immunol. 179 (2007) 5211-5219